Welcome to UCIR!
2020-02-14
Welcome to UCIR! Our website, Understanding Cancer Immunotherapy Research, aims to serve as a comprehensive resource of basic knowledge and up-to-date information on the breakthrough field of cancer immunotherapy. UCIR is for those affected by cancer – patients and caregivers – and for anyone who wants to learn more about this new pillar of cancer treatment.
On our website, you will:
- learn about the immune system and how it relates to cancer
- find detailed information about the different types of immunotherapies that exist or are in development
- explore our searchable database of approved immunotherapy drugs and learn about what types of cancers these drugs can treat, how they work, how well they work, and what their side effects may be
- expand your cancer immunotherapy vocabulary with our illustrated glossary
- navigate to additional resources, such as educational materials and other relevant websites
- keep up to date with the latest, most relevant developments and events in cancer immunotherapy research
Thank you for reading, and please remember to sign up for our newsletter!
References:
N/A
Nobel Prize recognizes the significance of cancer immunotherapy
As a testament to the significance of immunotherapy for the treatment of cancer, the 2018 Nobel Prize in Physiology or Medicine was awarded to Drs. James P. Allison and Tasuku Honjo "for their discovery of cancer therapy by inhibition of negative immune regulation". Dr. Allison discovered that a molecule called CTLA-4 acts as a brake on T cells and Dr. Honjo discovered another T cell brake called PD-1.
COVID-19: Implications and Guidance for Patients Treated with Immunotherapy
The coronavirus COVID-19 is considered a pandemic by the World Health Organization. Patients in high-risk categories should take extra precautions and contact their healthcare provider if symptoms emerge.
